Pulmonary elimination rate of inhaled99mTc-sestamibi radioaerosol is delayed in healthy cigarette smokers-Reference-Cited by-同舟云学术

Pulmonary elimination rate of inhaled99mTc-sestamibi radioaerosol is delayed in healthy cigarette smokers

Published:2008-04 Issue:4 Volume:65 Page:611-614
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Ruparelia Prina,Cheow Heok K.,Evans John W.,Banney Leith,Shankar Sonal,Szczepura Katherine R.,Swift Anna E.,Ballinger James R.,Hartman Neil G.,Chilvers Edwin R.,Peters A. Michael

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2008.03099.x/fullpdf

Reference15 articles.

1. Membrane transporter proteins: a challenge for CNS drug development

2. A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1

3. MDR1-Pgp 170 expression in human bronchus

4. Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition;Expert Opinion on Drug Delivery;2022-10-27

2. PET imaging to assess the impact of P-glycoprotein on pulmonary drug delivery in rats;Journal of Controlled Release;2022-02

3. Bronchopulmonary MDR protein expression may protect against COVID-19 infection;Nuclear Medicine Communications;2020-10

4. Red cell volume measurement: using technetium as a replacement for chromium;Nuclear Medicine Communications;2020-10

5. Assessing the Activity of Multidrug Resistance–Associated Protein 1 at the Lung Epithelial Barrier;Journal of Nuclear Medicine;2020-04-13